Deborah Alexis Meyers

Address:

244 Steeplechase Ln, Mocksville, NC 27028

Phone:

3369981095

VIN:

4JGBF22E87A240246

Make:

MERCEDES-BENZ

Model:

GL-CLASS

Year:

2007

US Patent:

6828103, Dec 7, 2004

Filed:

Feb 22, 2002

Appl. No.:

10/081563

Inventors:

David M. Herrington - Winston-Salem NC
Timothy D. Howard - Clemmons NC
Gregory A. Hawkins - High Point NC
Deborah A. Meyers - Mocksville NC

Assignee:

Wake Forest University - Winston-Salem NC

International Classification:

C12Q 168

US Classification:

435 6, 435 911, 435 912, 436 94, 536 2351, 536 2431

Abstract:

A method of screening a subject for increased likelihood of having a favorable response to estrogen replacement therapy comprises detecting the presence of the rare form of at least one estrogen receptor alpha polymorphism in the subject, the presence of the estrogen receptor alpha polymorphism indicating the subject is more likely to have a favorable response to estrogen replacement therapy (e. g. , with respect to cardiovascular health, heart disease, and/or HDL levels).

US Patent:

7122311, Oct 17, 2006

Filed:

Jul 12, 2002

Appl. No.:

10/194370

Inventors:

Paul Andrew Whittaker - Horsham West Sussex, GB
Deborah Alexis Meyers - Mocksville NC, US
Dirkje Sjoukje Postma - Groningen, NL
Eugene Roland Bleecker - Bermuda Run NC, US

Assignee:

Novartis AG - Basel
Wake Forest University Health Sciences - Winston-Salem NC
Rijksuniversiteit Groningen - Groningen

International Classification:

C12Q 1/68
C07H 21/02
C07H 21/04

US Classification:

435 6, 536 235, 536 2431

Abstract:

The invention relates to the use of an asthma-associated gene, designated AAGA, the protein molecule encoded by AAGA and related molecules in diagnostic and prognostic screening of patient populations, to polymorphisms in AAGA, and to the use of the protein encoded by AAGA or a variant thereof as a therapeutic target.

US Patent:

7579147, Aug 25, 2009

Filed:

Apr 30, 2003

Appl. No.:

10/426262

Inventors:

Jianfeng Xu - Clemmons NC, US
Deborah Meyers - Mocksville NC, US
Sigun Zheng - Clemmons NC, US
Patrick C. Walsh - Hunt Valley MD, US
William B. Isaacs - Glyndon MD, US
Eugene Bleecker - Winston-Salem NC, US
David Herrington - Winston Salem NC, US

Assignee:

Wake Forest University Health Sciences - Winston-Salem NC

International Classification:

C12Q 1/68

US Classification:

435 6

Abstract:

The present invention discloses methods of screening a subject for increased likelihood or risk of certain diseases or disorders. This method comprises detecting the presence or absence of at least one mutation in the MSR1 gene wherein the presence or absence of such mutation indicates an increased risk for certain diseases, such as cancer asthma and/or cardiovascular diseases.

US Patent:

8192928, Jun 5, 2012

Filed:

Jul 16, 2009

Appl. No.:

12/504034

Inventors:

Jianfeng Xu - Clemmons NC, US
Deborah Meyers - Mocksville NC, US
Sigun Zheng - Clemmons NC, US
Patrick C. Walsh - Hunt Valley MD, US
William B. Isaacs - Glyndon MD, US
Eugene Bleecker - Winston-Salem NC, US
David Herrington - Winston Salem NC, US

Assignee:

Wake Forest University Health Sciences - Winston-Salem NC

International Classification:

C12Q 1/68

US Classification:

435 6

Abstract:

The present invention discloses methods of screening a subject for increased likelihood or risk of certain diseases or disorders. This method comprises detecting the presence or absence of at least one mutation in the MSR1 gene wherein the presence or absence of such mutation indicates an increased risk for certain diseases, such as cancer asthma and/or cardiovascular diseases.